I'm going to do a little math tonight. I doubt the four idiots on this board will be able to follow even though they can read...
These numbers apply to a different stock and company but what I am presenting will cleave Grip's "boys" from his undies because the Gripper has pounded the table that by June, CYDY's stock price will be ten cents. I'll go even further and state that CYDY is not going bankrupt for a couple of good reasons tied to the numbers from a different company. Check it out. I copied these numbers from a poster on another board. The closing price of this company today is about $5.80 a share.
I think $9 is reasonable based on my modeling. Here is what I have for NonGAAP '24:
$1,757.8 Revenue
$733.9 Gross Margin
$351.6 Research and Development
$165.2 Sales and Marketing
$104.6 General and Administrative
$621.4 OPEX
$112.5 Operating Income
$13.5 Tax
$99.0 Net Income
R&D is higher YoY due to spending on hyperscale
G&A is slightly lower YoY due to lower fees from EY (restatement issue behind them)
Total EPS is 0.37 cents which is about a 28% increase YoY (Not sure what Q4 '23 EPS is quite yet). Assuming no irrational exuberance on the stock price, this derives a $9.13 price target. If the street goes a little nuts and gets ahead of its skis a little bit, it is possible we can see $11 by the end of the year.
The company is Infinera and do you know who the Founder and CTO is???? What he has in common with CYDY?
David Welch. Welch owns close to 50 MILLION shares of CYDY. Based on INFN's trajectory and stature in the field of optical networks, Welch is not
going to allow CYDY to fail. Have you seen that he owns two other biotechs? Get a grip, Grip. You're an idiot for stating your hubris.
Bullish
